Towards virtual histology with X-ray grating interferometry.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 06 2023
Historique:
received: 23 12 2022
accepted: 24 05 2023
medline: 5 6 2023
pubmed: 4 6 2023
entrez: 3 6 2023
Statut: epublish

Résumé

Breast cancer is the most common type of cancer worldwide. Diagnosing breast cancer relies on clinical examination, imaging and biopsy. A core-needle biopsy enables a morphological and biochemical characterization of the cancer and is considered the gold standard for breast cancer diagnosis. A histopathological examination uses high-resolution microscopes with outstanding contrast in the 2D plane, but the spatial resolution in the third, Z-direction, is reduced. In the present paper, we propose two high-resolution table-top systems for phase-contrast X-ray tomography of soft-tissue samples. The first system implements a classical Talbot-Lau interferometer and allows to perform ex-vivo imaging of human breast samples with a voxel size of 5.57 μm. The second system with a comparable voxel size relies on a Sigray MAAST X-ray source with structured anode. For the first time, we demonstrate the applicability of the latter to perform X-ray imaging of human breast specimens with ductal carcinoma in-situ. We assessed image quality of both setups and compared it to histology. We showed that both setups made it possible to target internal features of breast specimens with better resolution and contrast than previously achieved, demonstrating that grating-based phase-contrast X-ray CT could be a complementary tool for clinical histopathology.

Identifiants

pubmed: 37270642
doi: 10.1038/s41598-023-35854-6
pii: 10.1038/s41598-023-35854-6
pmc: PMC10239461
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9049

Informations de copyright

© 2023. The Author(s).

Références

Eur J Radiol. 2020 Aug;129:109077
pubmed: 32446126
Nat Commun. 2014 May 15;5:3797
pubmed: 24827387
Phys Med. 2020 Nov;79:93-102
pubmed: 33212423
Opt Express. 2014 Dec 15;22(25):30394-409
pubmed: 25606986
Opt Express. 2016 Oct 31;24(22):25129-25147
pubmed: 27828452
Ultramicroscopy. 2015 Oct;157:35-47
pubmed: 26057688
Invest Radiol. 2011 Dec;46(12):801-6
pubmed: 21788904
Nat Methods. 2021 Dec;18(12):1532-1541
pubmed: 34737453
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
Am J Physiol Lung Cell Mol Physiol. 2020 Jan 1;318(1):L65-L75
pubmed: 31596108
Sci Rep. 2016 Apr 04;6:24022
pubmed: 27040492
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):6940-6945
pubmed: 29915047
Int J Cancer. 2017 Aug 15;141(4):671-677
pubmed: 28457023
Opt Express. 2005 Aug 8;13(16):6296-304
pubmed: 19498642
Front Neurosci. 2020 Nov 09;14:584161
pubmed: 33240038
Eur J Radiol. 2008 Dec;68(3 Suppl):S58-62
pubmed: 18617344
Am J Pathol. 2019 Aug;189(8):1608-1620
pubmed: 31125553
Phys Med Biol. 2015 May 21;60(10):4123-35
pubmed: 25933258
Radiology. 2011 Jun;259(3):684-94
pubmed: 21436089
Acta Radiol. 2010 Oct;51(8):866-84
pubmed: 20799921
Nanoscale Horiz. 2020 May 1;5(5):869-879
pubmed: 32100775
ILAR J. 2018 Dec 1;59(1):66-79
pubmed: 30535284
Opt Express. 2021 Jan 18;29(2):2049-2064
pubmed: 33726406
Nat Mater. 2008 Feb;7(2):134-7
pubmed: 18204454
Radiology. 2000 Apr;215(1):286-93
pubmed: 10751500
J Struct Biol. 2011 Nov;176(2):250-3
pubmed: 21840398
Sci Rep. 2022 Feb 15;12(1):2485
pubmed: 35169138
J Electrochem Soc. 2021;168(8):
pubmed: 36938320
Lancet Digit Health. 2021 Nov;3(11):e733-e744
pubmed: 34711378
Phys Med Biol. 2013 Jan 7;58(1):R1-35
pubmed: 23220766
Nat Protoc. 2021 Oct;16(10):4564-4610
pubmed: 34480130
J Struct Biol. 2005 Sep;151(3):250-62
pubmed: 16125414
J Phys Condens Matter. 2021 Jul 13;33(36):
pubmed: 34167096
PLoS One. 2019 Jan 9;14(1):e0210291
pubmed: 30625220
Nat Methods. 2013 Jun;10(6):557-62
pubmed: 23624665
BMC Biol. 2020 Feb 27;18(1):21
pubmed: 32103752
Radiology. 2021 Nov;301(2):389-395
pubmed: 34427464
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34140413
Cancer Causes Control. 2004 Aug;15(6):543-50
pubmed: 15280633
Philos Trans A Math Phys Eng Sci. 2014 Jan 27;372(2010):20130025
pubmed: 24470410
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34183413
IEEE Trans Med Imaging. 2018 Dec;37(12):2642-2650
pubmed: 29994112
Breast Cancer Res Treat. 2019 Apr;174(2):279-296
pubmed: 30506111
Acta Crystallogr D Struct Biol. 2019 Nov 1;75(Pt 11):947-958
pubmed: 31692469
Phys Med Biol. 2019 Aug 07;64(15):155010
pubmed: 31234149
J Biomed Sci. 2021 Jun 7;28(1):42
pubmed: 34098949
Eur Radiol. 2020 Mar;30(3):1419-1425
pubmed: 31440834
Ann Oncol. 2011 Apr;22(4):863-869
pubmed: 20924073
Eur Radiol. 2015 Dec;25(12):3659-68
pubmed: 25956934
Eur Radiol Exp. 2022 Mar 1;6(1):9
pubmed: 35229244
Philos Trans A Math Phys Eng Sci. 2014 Jan 27;372(2010):20130027
pubmed: 24470411
J Cancer Res Clin Oncol. 2021 Mar;147(3):749-754
pubmed: 33284380
Sci Rep. 2021 Jul 7;11(1):14020
pubmed: 34234175
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):
pubmed: 35131900
J Struct Biol. 2013 Sep;183(3):363-367
pubmed: 23684965

Auteurs

M Polikarpov (M)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland. mpolikarpov@ethz.ch.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland. mpolikarpov@ethz.ch.

J Vila-Comamala (J)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.

Z Wang (Z)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.
Department of Engineering Physics, Tsinghua University, Haidian District, Beijing, 100080, China.

A Pereira (A)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

S van Gogh (S)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

C Gasser (C)

Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

K Jefimovs (K)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.

L Romano (L)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

Z Varga (Z)

Department of Pathology and Molecular Pathology, University Hospital Zürich, 8091, Zurich, Switzerland.

K Lång (K)

Department of Diagnostic Radiology, Translational Medicine, Lund University, Lund, Sweden.
Unilabs Mammography Unit, Skåne University Hospital, Malmö, Sweden.

M Schmeltz (M)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.

S Tessarini (S)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

M Rawlik (M)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

E Jermann (E)

EPFL, Lausanne, Switzerland.

S Lewis (S)

Sigray Inc., Concord, CA, 94520, USA.

W Yun (W)

Sigray Inc., Concord, CA, 94520, USA.

M Stampanoni (M)

Swiss Light Source, Paul Scherrer Institut, 5232, Villigen-PSI, Switzerland.
Institute for Biomedical Engineering, ETH Zurich, 8092, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH